https://test.ccga.io/index.php?action=history&feed=atom&title=HAEM4%3APrecursor_Lymphoid_Neoplasms 2026-04-30T21:36:35Z Revision history for this page on the wiki MediaWiki 1.43.5 https://test.ccga.io/index.php?title=HAEM4:Precursor_Lymphoid_Neoplasms&diff=13239&oldid=prev 2023-12-04T21:30:20Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:30, 4 December 2023</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l17">Line 17:</td> <td colspan="2" class="diff-lineno">Line 17:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==WHO Classification Pages (Includes Links to Content)==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==WHO Classification Pages (Includes Links to Content)==</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B-<del style="font-weight: bold; text-decoration: none;">Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma </del>with <del style="font-weight: bold; text-decoration: none;">t(9;22)(q34.1;q11.2); </del>BCR<del style="font-weight: bold; text-decoration: none;">-</del>ABL1|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B-<ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma </ins>with BCR<ins style="font-weight: bold; text-decoration: none;">::</ins>ABL1 <ins style="font-weight: bold; text-decoration: none;">fusion</ins>|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B<del style="font-weight: bold; text-decoration: none;">-Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma </del>with <del style="font-weight: bold; text-decoration: none;">t(v;11q23.3); </del>KMT2A<del style="font-weight: bold; text-decoration: none;">-Rearranged</del>|B-ALL with t(v;11q23.3); KMT2A-Rearranged]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B <ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma </ins>with KMT2A <ins style="font-weight: bold; text-decoration: none;">rearrangement</ins>|B-ALL with t(v;11q23.3); KMT2A-Rearranged]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B<del style="font-weight: bold; text-decoration: none;">-Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma </del>with <del style="font-weight: bold; text-decoration: none;">t(12;21)(p13.2;q22.1); </del>ETV6<del style="font-weight: bold; text-decoration: none;">-</del>RUNX1|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B <ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma </ins>with ETV6<ins style="font-weight: bold; text-decoration: none;">::</ins>RUNX1 <ins style="font-weight: bold; text-decoration: none;">fusion</ins>|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B-<del style="font-weight: bold; text-decoration: none;">Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma </del>with <del style="font-weight: bold; text-decoration: none;">Hyperdiploidy</del>|B-ALL with Hyperdiploidy]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B-<ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma </ins>with <ins style="font-weight: bold; text-decoration: none;">high hyperdiploidy</ins>|B-ALL with Hyperdiploidy]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B-<del style="font-weight: bold; text-decoration: none;">Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma </del>with <del style="font-weight: bold; text-decoration: none;">Hypodiploidy</del>|B-ALL with Hypodiploidy]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B-<ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma </ins>with <ins style="font-weight: bold; text-decoration: none;">hypodiploidy</ins>|B-ALL with Hypodiploidy]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B<del style="font-weight: bold; text-decoration: none;">-Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma </del>with <del style="font-weight: bold; text-decoration: none;">t(5;14)(q31.1;q32.1); </del>IGH<del style="font-weight: bold; text-decoration: none;">/</del>IL3|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B <ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma </ins>with IGH<ins style="font-weight: bold; text-decoration: none;">::</ins>IL3 <ins style="font-weight: bold; text-decoration: none;">fusion</ins>|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B<del style="font-weight: bold; text-decoration: none;">-Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma </del>with <del style="font-weight: bold; text-decoration: none;">t(1;19)(q23;p13.3); </del>TCF3<del style="font-weight: bold; text-decoration: none;">-</del>PBX1|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B <ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma </ins>with TCF3<ins style="font-weight: bold; text-decoration: none;">::</ins>PBX1 <ins style="font-weight: bold; text-decoration: none;">fusion</ins>|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B-<del style="font-weight: bold; text-decoration: none;">Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma, </del>BCR<del style="font-weight: bold; text-decoration: none;">-</del>ABL1-<del style="font-weight: bold; text-decoration: none;">Like</del>|B-ALL, BCR-ABL1-Like]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B-<ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma with </ins>BCR<ins style="font-weight: bold; text-decoration: none;">::</ins>ABL1-<ins style="font-weight: bold; text-decoration: none;">like features</ins>|B-ALL, BCR-ABL1-Like]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B-<del style="font-weight: bold; text-decoration: none;">Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma </del>with iAMP21|B-ALL with iAMP21]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B-<ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma </ins>with iAMP21|B-ALL with iAMP21]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[B-<del style="font-weight: bold; text-decoration: none;">Lymphoblastic Leukemia</del>/<del style="font-weight: bold; text-decoration: none;">Lymphoma, Not Otherwise Specified</del>|B-ALL, Not Otherwise Specified]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>B-<ins style="font-weight: bold; text-decoration: none;">lymphoblastic leukaemia</ins>/<ins style="font-weight: bold; text-decoration: none;">lymphoma</ins>|B-ALL, Not Otherwise Specified]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[Early T-<del style="font-weight: bold; text-decoration: none;">Cell Precursor Lymphoblastic Leukemia</del>]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM5:</ins>Early T-<ins style="font-weight: bold; text-decoration: none;">precursor lymphoblastic leukaemia / lymphoma</ins>]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>   - [[NK-Lymphoblastic Leukemia/Lymphoma]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>   - [[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>NK-Lymphoblastic Leukemia/Lymphoma]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Other Related Pages (Includes Links to Content)==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Other Related Pages (Includes Links to Content)==</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[T-ALL/MEF2C]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>T-ALL/MEF2C]]</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[T-cell lymphoblastic leukemia with t(7;14)(p15;q32)]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[<ins style="font-weight: bold; text-decoration: none;">HAEM4:</ins>T-cell lymphoblastic leukemia with t(7;14)(p15;q32)]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Additional Information==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Additional Information==</div></td></tr> <!-- diff cache key wikidatabase:diff:1.41:old-12433:rev-13239:php=table --> </table>

Bailey.Glen https://test.ccga.io/index.php?title=HAEM4:Precursor_Lymphoid_Neoplasms&diff=12433&oldid=prev 2023-11-03T18:08:25Z

<p>Created page with &quot;{{Under Construction}} ==Primary Author(s)*== Put your text here __TOC__ ==Graphical Data Links== Put your graphics here ==General Disease Overview / Description of Canc...&quot;</p> <p><b>New page</b></p><div>{{Under Construction}}<br /> <br /> ==Primary Author(s)*==<br /> <br /> Put your text here<br /> <br /> __TOC__<br /> <br /> ==Graphical Data Links==<br /> <br /> Put your graphics here<br /> <br /> ==General Disease Overview / Description of Cancer Category==<br /> <br /> Put your text here<br /> <br /> ==WHO Classification Pages (Includes Links to Content)==<br /> <br /> *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]]<br /> <br /> - [[B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged|B-ALL with t(v;11q23.3); KMT2A-Rearranged]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy|B-ALL with Hyperdiploidy]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy|B-ALL with Hypodiploidy]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like|B-ALL, BCR-ABL1-Like]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma with iAMP21|B-ALL with iAMP21]]<br /> - [[B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified|B-ALL, Not Otherwise Specified]]<br /> <br /> *[[T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]]<br /> <br /> - [[Early T-Cell Precursor Lymphoblastic Leukemia]]<br /> - [[NK-Lymphoblastic Leukemia/Lymphoma]]<br /> <br /> ==Other Related Pages (Includes Links to Content)==<br /> <br /> *[[B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4]]<br /> *[[B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6]]<br /> *[[B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)]]<br /> *[[B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions]]<br /> *[[B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements]]<br /> *[[B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)]]<br /> *[[T-ALL/MEF2C]]<br /> *[[T-cell lymphoblastic leukemia with t(7;14)(p15;q32)]]<br /> <br /> ==Additional Information==<br /> <br /> Put your text here<br /> <br /> ==References==<br /> <br /> ===EXAMPLE Book===<br /> <br /> #Arber DA, et al., (2008). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Editors. IARC Press: Lyon, France, p117-118.<br /> <br /> ==Notes==<br /> &lt;nowiki&gt;*&lt;/nowiki&gt;Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.<br /> <br /> <br /> <br /> <br /> [[Category:Structural Abnormalities]]<br /> [[Category:Translocation]]<br /> [[Category:Amplification Chromosome 21]]<br /> [[Category:Structural Chromosome Abnormalities in ALL]]<br /> [[Category:Karyotypic Patterns]]<br /> [[Category:Oncogenes in ALL]]<br /> [[Category:Fusion Genes in ALL]]<br /> [[Category:Recently Added Pages]]</div>

Bailey.Glen